187 related articles for article (PubMed ID: 17138568)
1. SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses.
Orr SJ; Morgan NM; Buick RJ; Boyd CR; Elliott J; Burrows JF; Jefferies CA; Crocker PR; Johnston JA
J Biol Chem; 2007 Feb; 282(6):3418-22. PubMed ID: 17138568
[TBL] [Abstract][Full Text] [Related]
2. CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover.
Orr SJ; Morgan NM; Elliott J; Burrows JF; Scott CJ; McVicar DW; Johnston JA
Blood; 2007 Feb; 109(3):1061-8. PubMed ID: 17008544
[TBL] [Abstract][Full Text] [Related]
3. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
5. Siglec-6 Signaling Uses Src Kinase Tyrosine Phosphorylation and SHP-2 Recruitment.
Stefanski AL; Renecle MD; Kramer A; Sehgal S; Narasimhan P; Rumer KK; Winn VD
Cells; 2022 Oct; 11(21):. PubMed ID: 36359823
[TBL] [Abstract][Full Text] [Related]
6. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.
Avril T; Freeman SD; Attrill H; Clarke RG; Crocker PR
J Biol Chem; 2005 May; 280(20):19843-51. PubMed ID: 15769739
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of MIS, a myeloid inhibitory siglec, that binds protein-tyrosine phosphatases SHP-1 and SHP-2.
Ulyanova T; Shah DD; Thomas ML
J Biol Chem; 2001 Apr; 276(17):14451-8. PubMed ID: 11278955
[TBL] [Abstract][Full Text] [Related]
8. Basic and clinical immunology of Siglecs.
von Gunten S; Bochner BS
Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
[TBL] [Abstract][Full Text] [Related]
9. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs.
Yamaji T; Mitsuki M; Teranishi T; Hashimoto Y
Glycobiology; 2005 Jul; 15(7):667-76. PubMed ID: 15703304
[TBL] [Abstract][Full Text] [Related]
10. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
[TBL] [Abstract][Full Text] [Related]
11. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
Linnartz-Gerlach B; Mathews M; Neumann H
Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
[TBL] [Abstract][Full Text] [Related]
12. Tools to study and target the Siglec-sialic acid axis in cancer.
Läubli H; Kawanishi K; George Vazhappilly C; Matar R; Merheb M; Sarwar Siddiqui S
FEBS J; 2021 Nov; 288(21):6206-6225. PubMed ID: 33251699
[TBL] [Abstract][Full Text] [Related]
13. High-affinity ligands of Siglec receptors and their therapeutic potentials.
Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of S2V, a novel putative siglec that contains two V set Ig-like domains and recruits protein-tyrosine phosphatases SHPs.
Yu Z; Lai CM; Maoui M; Banville D; Shen SH
J Biol Chem; 2001 Jun; 276(26):23816-24. PubMed ID: 11328818
[TBL] [Abstract][Full Text] [Related]
15. Siglec-9 and SHP-1 are differentially expressed in neonatal and adult neutrophils.
Rashmi R; Bode BP; Panesar N; King SB; Rudloff JR; Gartner MR; Koenig JM
Pediatr Res; 2009 Sep; 66(3):266-71. PubMed ID: 19542910
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of leucocyte functions by CD33-related siglecs.
Avril T; Attrill H; Zhang J; Raper A; Crocker PR
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1024-7. PubMed ID: 17073742
[TBL] [Abstract][Full Text] [Related]
17. The role of the Siglec-G ITIM domain during bacterial infection.
Wu Y; Yang D; Chen GY
Cell Mol Biol (Noisy-le-grand); 2022 Jan; 67(4):163-169. PubMed ID: 35809291
[TBL] [Abstract][Full Text] [Related]
18. Siglec-F Promotes IL-33-Induced Cytokine Release from Bone Marrow-Derived Eosinophils Independently of the ITIM and ITIM-like Motif Phosphorylation.
Westermann S; Dietschmann A; Doehler D; Castiglione K; Bochner BS; Voehringer D; Radtke D
J Immunol; 2022 Feb; 208(3):732-744. PubMed ID: 34996839
[TBL] [Abstract][Full Text] [Related]
19. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
Nitschke L
Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
[TBL] [Abstract][Full Text] [Related]
20. Non-canonical roles of Siglecs: Beyond sialic acid-binding and immune cell modulation.
Siddiqui SS
Mol Aspects Med; 2023 Apr; 90():101145. PubMed ID: 36153172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
